ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105014 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105014; 2) Community: the network communities that were significantly associated with the response to NSC 105014; 3) Molecule: the relationships between components within communities and NSC 105014; 4) MDR: the compounds that were significantly associated with the NSC 105014.

NSC Compound Enrichment Correlation
NSC 52427 Null 0.00433056621075589 0.27687958
NSC 631534 Null 0.00433056621075589 0.26958124
NSC 650025 Null 0.00433056621075589 0.26836539
NSC 699168 Null 0.00433056621075589 0.25782887
NSC 716260 Null 0.00433056621075589 0.14155677
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.00433056621075589 0.071169692
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00567322425730621 0.21591412
NSC 18805 .gamma.-Thujaplicine 0.00567322425730621 0.31287989
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.00567322425730621 0.24284498
NSC 300289 Pinafide 0.00567322425730621 0.28194369
Total:75  Current:11    [First] [Prev] [Next] [Last]